Patent ductus arteriosus in the preterm infant: a survey of clinical practices in French neonatal intensive care units

Pediatr Cardiol. 2011 Jun;32(5):607-14. doi: 10.1007/s00246-011-9925-8. Epub 2011 Mar 1.

Abstract

Patent ductus arteriosus (PDA) is one of the most common problems in the care of premature infants, especially the extremely premature. There is no real consensus regarding the diagnostic criteria or treatment of a hemodynamically significant PDA. Its diagnosis, assessment, and treatment still remain challenges. Therefore, we investigated clinical practices in French tertiary neonatology centers regarding the management of PDA to compare their similarities and differences. We sent a questionnaire by email to the PDA specialist in every French tertiary neonatal intensive care unit. It contained 27 items regarding the unit's structure, method of diagnosing PDA, and treatment choices. The completed questionnaire were returned via email and analyzed blindly. The questionnaire response rate was 87.5%, which allowed us to draw some conclusions regarding French clinical practices in the care of neonates with PDA. Although the diagnostic criteria are quite similar, the therapeutic practices are rather different across neonatal care units. We highlight the great variability in French clinical practices when it comes to treating PDA and underscore the necessity for harmonization of these practices, which could be achieved using multicenter, randomized studies to identify the advantages of one approach compared with another.

Publication types

  • Comparative Study

MeSH terms

  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use*
  • Contraindications
  • Data Collection
  • Dose-Response Relationship, Drug
  • Drug Administration Schedule
  • Ductus Arteriosus, Patent / diagnosis
  • Ductus Arteriosus, Patent / drug therapy*
  • Ductus Arteriosus, Patent / mortality
  • Ductus Arteriosus, Patent / surgery*
  • Echocardiography
  • France
  • Humans
  • Ibuprofen / therapeutic use*
  • Indomethacin / therapeutic use*
  • Infant, Newborn
  • Infant, Premature, Diseases / diagnosis
  • Infant, Premature, Diseases / drug therapy*
  • Infant, Premature, Diseases / mortality
  • Infant, Premature, Diseases / surgery*
  • Intensive Care Units, Neonatal*
  • Ligation
  • Recurrence
  • Retreatment
  • Surveys and Questionnaires*

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Ibuprofen
  • Indomethacin